We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-13.53%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.16%
AUM
$4.65B
AUM Growth
-$902M
Cap. Flow
-$55.6M
Cap. Flow %
-1.2%
Top 10 Hldgs %
17.2%
Holding
1,576
New
113
Increased
560
Reduced
639
Closed
173

Sector Composition

Rank Sector Weight
1 Technology 16.34%
2 Healthcare 11.48%
3 Financials 11.22%
4 Industrials 8.07%
5 Consumer Discretionary 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
1301
Tvardi Therapeutics
TVRD
$19M
$156K ﹤0.01%
476
+129
+37% +$45.3K
HUGS
1302
DELISTED
USHG Acquisition Corp.
HUGS
$155K ﹤0.01%
15,800
-1,300
-8% -$13K
VALE icon
1303
Vale
VALE
$61.8B
$153K ﹤0.01%
+10,478
New +$179K
JRO
1304
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$153K ﹤0.01%
18,762
+78
+0.4% +$700
MWA icon
1305
Mueller Water Products
MWA
$4.02B
$152K ﹤0.01%
12,978
BOE icon
1306
BlackRock Enhanced Global Dividend Trust
BOE
$679M
$150K ﹤0.01%
15,344
+113
+0.7% +$1.19K
OGCP
1307
Empire State Realty Series 60
OGCP
$1.47B
$150K ﹤0.01%
21,474
HIE
1308
DELISTED
Miller/Howard High Income Equity Fund
HIE
$146K ﹤0.01%
15,632
+3,540
+29% +$36.7K
HIMX
1309
Himax Technologies
HIMX
$2.23B
$145K ﹤0.01%
+19,300
New +$178K
EQRX
1310
DELISTED
EQRx, Inc. Common Stock
EQRX
$145K ﹤0.01%
+31,000
New +$140K
BGY icon
1311
BlackRock Enhanced International Dividend Trust
BGY
$528M
$142K ﹤0.01%
28,047
-6,479
-19% -$34.6K
JRS icon
1312
Nuveen Real Estate Income Fund
JRS
$251M
$141K ﹤0.01%
14,996
+112
+0.8% +$1.18K
FAM
1313
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
$141K ﹤0.01%
23,287
+140
+0.6% +$928
CD
1314
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$140K ﹤0.01%
18,000
LICY
1315
DELISTED
Li-Cycle Holdings Corp.
LICY
$139K ﹤0.01%
+2,531
New +$148K
MSOS icon
1316
AdvisorShares Pure US Cannabis ETF
MSOS
$848M
$138K ﹤0.01%
13,371
+650
+5% +$9.65K
IVH
1317
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
$134K ﹤0.01%
13,100
GBDC icon
1318
Golub Capital BDC
GBDC
$3.43B
$131K ﹤0.01%
+10,118
New +$145K
CRNT icon
1319
Ceragon Networks
CRNT
$197M
$126K ﹤0.01%
49,000
-19,500
-28% -$37.2K
KOPN icon
1320
Kopin
KOPN
$687M
$126K ﹤0.01%
112,500
-42,500
-27% -$63.8K
HIO
1321
Western Asset High Income Opportunity Fund
HIO
$336M
$125K ﹤0.01%
31,527
WIW
1322
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$507M
$124K ﹤0.01%
11,800
IONQ icon
1323
IonQ
IONQ
$14.8B
$122K ﹤0.01%
27,785
+10,285
+59% +$72.8K
BBBY
1324
DELISTED
Bed Bath & Beyond Inc
BBBY
$122K ﹤0.01%
24,463
+11,813
+93% +$137K
DCF
1325
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$119K ﹤0.01%
+16,180
New +$129K

Similar funds

Oppenheimer & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Oppenheimer & Co held 1,576 positions worth $4.65B, down 16% from $5.55B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q2 2022 filing shows 113 new, 560 increased, 639 reduced and 173 closed positions. Its largest new stake was Warner Bros: 379,857 shares worth $5.1M. The largest sale was abrdn Physical Gold Shares ETF, an estimated $12.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q2 2022 buy was Warner Bros: 379,857 shares worth $5.1M.
  • Oppenheimer & Co added most to State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q2 2022, an estimated $11.4M increase.
  • Oppenheimer & Co's biggest Q2 2022 reduction was Apple, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited abrdn Physical Gold Shares ETF in Q2 2022, selling an estimated $12.8M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $4.65B portfolio in Q2 2022.
  • Oppenheimer & Co opened 113 new positions and closed 173 in Q2 2022.
  • Oppenheimer & Co's portfolio value fell 16% quarter-over-quarter to $4.65B.

Based on Oppenheimer & Co's 13F filing for Q2 2022, filed 8 Aug 2022.